+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Drug Pricing"

Pharmaceutical Pricing and Reimbursement: Global Markets - Product Thumbnail Image

Pharmaceutical Pricing and Reimbursement: Global Markets

  • Report
  • July 2020
  • 164 Pages
  • Global
From
Latest Trends in Orphan Drug Pricing and Reimbursement - Product Thumbnail Image

Latest Trends in Orphan Drug Pricing and Reimbursement

  • Report
  • February 2018
  • 135 Pages
  • Global
From
From
Trump's Drug Pricing 'Dream Team' And Prospects For Change - Product Thumbnail Image

Trump's Drug Pricing 'Dream Team' And Prospects For Change

  • Report
  • November 2018
  • 3 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

The Drug Pricing market is an important part of Pharmacoeconomics, which is the study of the cost-effectiveness of pharmaceuticals. It involves the analysis of the cost of drugs, the value of their therapeutic benefits, and the impact of their pricing on the healthcare system. Drug pricing is a complex process that involves multiple stakeholders, including pharmaceutical companies, health insurers, and government agencies. It is also influenced by factors such as the availability of generic drugs, the cost of research and development, and the cost of production. The Drug Pricing market is highly competitive, with companies competing to offer the best prices and the most effective drugs. Companies in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, Johnson & Johnson, and AstraZeneca. Show Less Read more